Effect of Esomeprazole on the Pharmacokinetics of Oral Treprostinil
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Pulmonary Arterial Hypertension
Related studies linked through entity extraction aliases.
Effect of Food on the Pharmacokinetics of Oral Treprostinil
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of Fluoxetine in Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- PHASE2
Biomarkers in the Evaluation of Chronic Lung Disease
- Status
- COMPLETED
- Phase
- N/A
Ventavis® Registry Protocol
- Status
- TERMINATED
- Phase
- N/A
Imatinib (QTI571) in Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- PHASE3
Open Label Access Study Of Sildenafil In Adult Patients With Pulmonary Arterial Hypertension Completing A1481244 Study
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Local Open-Label Access Study For Patients Who Completed A1481244 Study In Brazil
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Study of Cicletanine for Pulmonary Arterial Hypertension (PAH)
- Status
- TERMINATED
- Phase
- PHASE2
Dose-Finding, Safety, Pharmacodynamic Effect Study of Sodium Nitrite Inhalation Solution in Normal, Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
A Long-Term, Open-Label Study to Evaluate the Safety of Sitaxsentan Sodium Treatment in Patients With Pulmonary Arterial Hypertension
- Status
- TERMINATED
- Phase
- PHASE3
The Expression and Significance of MiRNA
- Status
- COMPLETED
- Phase
- N/A
Study Looking at Combination Therapy (Sitaxsentan+Sildenafil) Vs. Monotherapy (Sitaxsentan Alone) SR-PAAS -Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil
- Status
- TERMINATED
- Phase
- PHASE3
Study Providing Monotherapy (Sitaxsentan) And Combination Therapy (Sitaxsentan+Sildenafil) To Subjects With Pulmonary Arterial Hypertension (PAH) To Assess Long-Term Safety
- Status
- TERMINATED
- Phase
- PHASE3
Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS)
- Status
- TERMINATED
- Phase
- PHASE3
An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Multi-Center, Open-Label, Multiple Dose, Dose Finding Study Exploring the Safety and Tolerability of Beraprost Sodium Modified Release in PAH Patients
- Status
- COMPLETED
- Phase
- PHASE2
Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in Pulmonary Arterial Hypertension (PAH) Subjects
- Status
- COMPLETED
- Phase
- PHASE4
Iloprost Power Disc-15 in Pulmonary Arterial Hypertension
- Status
- TERMINATED
- Phase
- PHASE3
Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder
- Status
- TERMINATED
- Phase
- N/A